Subscribe to RSS

DOI: 10.1055/a-2573-9069
Efficacy and safety of endoscopic intraperitoneal subserosal dissection for gastric submucosal tumors with extraluminal growth pattern
Authors
Supported by: Biomedical Support Project of Shanghai 21S31904000
Supported by: China Postdoctoral Science Foundation 2023M730664
Clinical Trial:
Registration number (trial ID): ChiCTR2200067022, Trial registry: Chinese Clinical Trial Registry (http://www.chictr.org/), Type of Study: Prospective single center study

Abstract
Background
Endoscopic intraperitoneal subserosal dissection (EISD) has been reported to be a promising modified tunneling technique for gastric submucosal tumors (SMTs) with a predominantly extraluminal growth pattern. We evaluated the safety and efficacy of EISD for gastric extraluminal SMTs.
Methods
We prospectively enrolled consecutive patients who underwent EISD for gastric extraluminal SMTs between October 2018 and March 2024. Clinicopathological characteristics and procedure-related parameters were analyzed.
Results
10 patients with 11 gastric extraluminal SMTs were included. The mean (SD) longest and shortest specimen diameters were 2.1 (0.9) cm (range 0.5–4.0) and 1.8 (0.7) cm (range 0.4–3.0), respectively. All SMTs (100%) were resected en bloc, and 10 (90.9%) were retrieved en bloc. The mean (SD) resection and suture times were 58.9 (31.5) minutes (range 26–125) and 12.4 (10.1) minutes (range 3–25), respectively. Two patients experienced type I mucosal injury at the tumor site, and no major adverse events occurred. The mean postoperative hospital stay was 3.4 (SD 0.8) days (range 3–5). No recurrence or metastasis occurred during a mean follow-up period of 32.1 (SD 18.8) months (range 7–71).
Conclusions
EISD appeared to be a feasible and safe method for removing gastric extraluminal SMTs in selected patients.
Publication History
Received: 09 December 2024
Accepted after revision: 02 April 2025
Accepted Manuscript online:
03 April 2025
Article published online:
15 May 2025
© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/).
Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
-
References
- 1 Sadeghi A, Zali MR, Tayefeh Norooz M. et al. Management of gastrointestinal subepithelial lesions: an answer to the conflicting opinions. Gastroenterol Hepatol Bed Bench 2023; 16: 378-385
- 2 Menon L, Buscaglia JM. Endoscopic approach to subepithelial lesions. Ther Adv Gastroenterol 2014; 7: 123
- 3 Koh YX, Chok AY, Zheng HL. et al. A systematic review and meta-analysis comparing laparoscopic versus open gastric resections for gastrointestinal stromal tumors of the stomach. Ann Surg Oncol 2013; 20: 3549-3560
- 4 Cai M-Y, Zhu B-Q, Xu M-D. et al. Submucosal tunnel endoscopic resection for extraluminal tumors: a novel endoscopic method for en bloc resection of predominant extraluminal growing subepithelial tumors or extra-gastrointestinal tumors (with videos). Gastrointest Endosc 2018; 88: 160-167
- 5 Zhai Y-Q, Chai N-L, Zhang W-G. et al. Endoscopic versus surgical resection in the management of gastric schwannomas. Surg Endosc 2021; 35: 6132-6138
- 6 Solaini L, Cavaliere D, Fico V. et al. Open versus laparoscopic versus robotic gastric gastrointestinal stromal tumour resections: a multicentre cohort study. Int J Med Robot 2021; 17: e2198
- 7 Liu X, Chen T, Cheng J. et al. Endoscopic transmural route for dissection of gastric submucosal tumors with extraluminal growth: experience in two cases. Gut 2021; 70: 2052-2054
- 8 Joensuu H. Risk stratification of patients diagnosed with gastrointestinal stromal tumor. Hum Pathol 2008; 39: 1411-1419
- 9 Cotton PB, Eisen GM, Aabakken L. et al. A lexicon for endoscopic adverse events: report of an ASGE workshop. Gastrointest Endosc 2010; 71: 446-454
- 10 Wang Y, Liu Z-Q, Xu M-D. et al. Clinical and endoscopic predictors for intraprocedural mucosal injury during per-oral endoscopic myotomy. Gastrointest Endosc 2019; 89: 769-778
- 11 Shi Q, Chen T, Zhong Y-S. et al. Complete closure of large gastric defects after endoscopic full-thickness resection, using endoloop and metallic clip interrupted suture. Endoscopy 2013; 45: 329-334
- 12 Gong Y, Wang J, Chen T. et al. New endoscopic closure technique, “internal traction-assisted suspended closure,” for GI defect closure: a pilot study (with video). Gastrointest Endosc 2024; 99: 186-192.e1
- 13 Li Q-L, Chen W-F, Zhang C. et al. Clinical impact of submucosal tunneling endoscopic resection for the treatment of gastric submucosal tumors originating from the muscularis propria layer (with video). Surg Endosc 2015; 29: 3640-3646
- 14 Chen H, Li B, Li L. et al. Current status of endoscopic resection of gastric subepithelial tumors. Am J Gastroenterol 2019; 114: 718-725
- 15 Cecinato P, Sinagra E, Laterza L. et al. Endoscopic removal of gastrointestinal lesions by using third space endoscopy techniques. Best Pract Res Clin Gastroenterol 2024; 71: 101931
- 16 Ma LY, Liu ZQ, Yao L. et al. Endoscopic resection of upper GI extraluminal tumors (with videos). Gastrointest Endosc 2022; 96: 752-763.e6
- 17 Chen T, Zhou PH, Chu Y. et al. Long-term outcomes of submucosal tunneling endoscopic resection for upper gastrointestinal submucosal tumors. Ann Surg 2017; 265: 363-369
- 18 Liu Z, Zhang X, Zhang W. et al. Comprehensive evaluation of the learning curve for peroral endoscopic myotomy. Clin Gastroenterol Hepatol 2018; 16: 1420-1426.e2
